XDNA.TO vs. HIG.TO
XDNA.TO (iShares Genomics Immunology and Healthcare Index ETF) and HIG.TO (Brompton Global Healthcare Income & Growth ETF) are both Health & Biotech Equities funds. XDNA.TO is passively managed, while HIG.TO is actively managed. Over the past 3 years, XDNA.TO returned 14.14%/yr vs 4.12%/yr for HIG.TO. At a 0.21 correlation, their price movements are largely independent.
Performance
XDNA.TO vs. HIG.TO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XDNA.TO achieves a 28.27% return, which is significantly higher than HIG.TO's -2.36% return.
XDNA.TO
- 1D
- -0.71%
- 1M
- 10.45%
- 6M
- 16.34%
- YTD
- 28.27%
- 1Y
- 59.77%
- 3Y*
- 14.14%
- 5Y*
- —
- 10Y*
- —
HIG.TO
- 1D
- 1.09%
- 1M
- 3.25%
- 6M
- -3.82%
- YTD
- -2.36%
- 1Y
- 8.50%
- 3Y*
- 4.12%
- 5Y*
- 0.89%
- 10Y*
- 5.34%
XDNA.TO vs. HIG.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF | 28.27% | 12.10% | 5.54% | -7.84% | -14.85% |
HIG.TO Brompton Global Healthcare Income & Growth ETF | -2.36% | 13.94% | -0.33% | -1.53% | 0.12% |
Correlation
The correlation between XDNA.TO and HIG.TO is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 4, 2022 | 0.21 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XDNA.TO vs. HIG.TO — Risk / Return Rank
XDNA.TO
HIG.TO
XDNA.TO vs. HIG.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare Index ETF (XDNA.TO) and Brompton Global Healthcare Income & Growth ETF (HIG.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XDNA.TO | HIG.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.76 | ||
| Sortino ratioReturn per unit of downside risk | +2.23 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.11 | +0.28 |
| Calmar ratioReturn relative to maximum drawdown | 6.95 | 0.60 | +6.35 |
| Martin ratioReturn relative to average drawdown | 15.82 | 1.41 | +14.41 |
Loading charts...
Drawdowns
XDNA.TO vs. HIG.TO - Drawdown Comparison
The maximum XDNA.TO drawdown since its inception was -45.90%, which is greater than HIG.TO's maximum drawdown of -31.83%. Use the drawdown chart below to compare losses from any high point for XDNA.TO and HIG.TO.
Loading charts...
Drawdown Indicators
| XDNA.TO | HIG.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.90% | -31.83% | -14.07% |
Max Drawdown (1Y)Largest decline over 1 year | -8.64% | -14.18% | +5.54% |
Max Drawdown (3Y)Largest decline over 3 years | -28.29% | -14.18% | -14.11% |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.58% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -31.83% | — |
Current DrawdownCurrent decline from peak | -7.51% | -6.98% | -0.53% |
Average DrawdownAverage peak-to-trough decline | -22.98% | -8.17% | -14.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.79% | 6.03% | -2.24% |
Volatility
XDNA.TO vs. HIG.TO - Volatility Comparison
iShares Genomics Immunology and Healthcare Index ETF (XDNA.TO) has a higher volatility of 7.90% compared to Brompton Global Healthcare Income & Growth ETF (HIG.TO) at 6.38%. This indicates that XDNA.TO's price experiences larger fluctuations and is considered to be riskier than HIG.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XDNA.TO | HIG.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.90% | 6.38% | +1.52% |
Volatility (6M)Calculated over the trailing 6-month period | 18.84% | 11.19% | +7.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.66% | 14.80% | +10.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.41% | 15.17% | +10.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.41% | 17.37% | +8.04% |
Dividends
XDNA.TO vs. HIG.TO - Dividend Comparison
XDNA.TO's dividend yield for the trailing twelve months is around 0.25%, less than HIG.TO's 8.91% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HIG.TO Brompton Global Healthcare Income & Growth ETF | 8.91% | 8.32% | 8.71% | 8.03% | 6.97% | 5.29% | 6.22% | 6.12% | 7.11% | 6.43% | 6.47% | 1.80% |
XDNA.TO iShares Genomics Immunology and Healthcare Index ETF | 0.25% | 0.43% | 0.32% | 0.25% | 0.32% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
XDNA.TO and HIG.TO have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
They also come from different issuers: iShares and Brompton.
Find the right allocation for XDNA.TO and HIG.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer